In contrast, although PD-L1 expression reflects the presence of tumor-infiltrating lymphocytes (TILs), there are reports that PD-L1 expression is a prognostic marker for resectable NSCLC harboring an EGFR mutation [68]. This evidence concerns the gene CD274 and neoplasm.